Probiodrug

Developing new therapeutic products for the treatment of Alzheimer’s disease

placeHalle, Saxony Anhalt, Germany calendar_todayFounded 1997 language probiodrug.de

Registered entities

Investor mix

12 investors on record; 3 have since exited.

Investor typeCountShare
Venture capital542%
Private equity650%
Other / undisclosed18%
Coming soon